Abstract
ABSTRACT. Type I hereditary tyrosinemia is characterized by the almost complete absence of fumarylacetoacetase in tissues and cells from patients. To investigate the -nature of the enzyme deficiency, extracts of tissues (liver and kidney) and cells (lymphocytes and fibroblasts) were immunochemically screened for the presence of fumarylacetoacetase enzyme protein. The antibodies used were raised in rabbits against fumarylacetoacetase purified from beef liver. These antibodies cross-reacted strongly with the human enzyme. No cross-reacting material was found in extracts from liver (n = 4) and kidney (n = 1) from patients. Extracts from lymphocytes and cultured skin fibroblasts from patients were investigated as well. However, no crossreacting material was found in extracts of these cells.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berger, R., Van Faassen, H., Taanman, J. et al. Type I Tyrosinemia: Lack of Immunologically Detectable Fumarylacetoacetase Enzyme Protein in Tissues and Cell Extracts. Pediatr Res 22, 394–398 (1987). https://doi.org/10.1203/00006450-198710000-00005
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198710000-00005
This article is cited by
-
A novel mutation causing mild, atypical fumarylacetoacetase deficiency (Tyrosinemia type I): a case report
Orphanet Journal of Rare Diseases (2009)
-
Cardiomyopathy in tyrosinaemia type I is common but usually benign
Journal of Inherited Metabolic Disease (2006)
-
Tyrosinemia: A Review
Pediatric and Developmental Pathology (2001)
-
Tyrosinaemia type 1 and glutathione synthetase deficiency: two disorders with reduced hepatic thiol group concentrations and a liver 4‐fumarylacetoacetate hydrolase deficiency
Journal of Inherited Metabolic Disease (1995)
-
Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase
Human Genetics (1994)